Kaur, Jyotroop
Martin, John A.
Vege, Santhi S.
Garimella, Vishal
Majumder, Shounak
Levy, Michael J.
Abu Dayyeh, Barham K.
Storm, Andrew C.
Vargas, Eric J.
Law, Ryan J.
Bofill, Aliana M.
Decker, G. Anton
Petersen, Bret T.
Chandrasekhara, Vinay https://orcid.org/0000-0001-6209-9905
Article History
Received: 25 January 2023
Accepted: 13 June 2023
First Online: 4 September 2023
Declarations
:
: JK, VG, SSV, EJV, JAM, MJL, SM, ABG, and GAD. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. RJL: Consultant—Boston Scientific, ConMed, Medtronic; Royalties—UpToDate. BKA: Consultant for Endogenex, Endo-TAGSS, Metamodix, and BFKW; consultant and grant/research support from USGI, Apollo Endosurgery, Medtronic, Spatz Medical, EndoGastric Solutions, Aspire Bariatrics, and Boston Scientific; Speaker roles with Olympus and Johnson and Johnson; and research support from Cairn Diagnostics and GI Dynamics. BTP: Advisor/consultant—Olympus America and Investigator, Grant support—Boston Scientific and Investigator, Grant support—Ambu, Inc., Consultant—Pentax, Inc., and Consultant—Pfizer, Inc. ACS: Research grants from Apollo Endosurgery, Boston Scientific, Endogenex, Endo-TAGSS, and Enterasense and consulting fees for Apollo Endosurgery, Boston Scientific, ERBE Elektromedizin, Intuitive, and Olympus. VC: Consultant—Boston Scientific, Covidien. LP: Research Funding from Micro-tech Endoscopy, Shareholder, and Nevakar Corporation.